Content Type: Article

  • Recent developments in tax law: return of deposits from third countries

    Recent developments in tax law: return of deposits from third countries

    ARTICLE

    Recent developments in tax law: return of deposits from third countries

    June 19, 2023

    Read time: 2 min

    Key takeaways
    Overview

    Dr Gero Burwitz with an article on “Recent developments in tax law: return of capital contributions from third countries”, published in Neue Zeitschrift für Gesellschaftsrecht (NZG), p. 776 ff. in June 2023.

    In depth
    Authors

    Dr. Gero Burwitz

    Partner

    Munich

    More insights

  • Decarbonization Journeys or Ideological Joyrides? A Look at ESG, Climate Change and US Insurers at Mid-2023

    Decarbonization Journeys or Ideological Joyrides? A Look at ESG, Climate Change and US Insurers at Mid-2023

    ARTICLE / CLIENT ALERT

    Decarbonization Journeys or Ideological Joyrides? A Look at ESG, Climate Change and US Insurers at Mid-2023

    June 16, 2023

    Read time: 11 min

    Key takeaways
    Overview

    With most state legislatures now finished with their 2023 sessions and with the East and West coasts preparing for peak hurricane and wildfire season, respectively, now is a good time to take stock of the environmental, social and governance (ESG) debates currently taking place in the United States, as well as the overall climate change regulatory environment for US insurers. It has been an extraordinary year thus far and will likely continue to be interesting with the upcoming 2024 presidential election.

    Reports from the mainstream press and in industry publications regarding ESG developments and insurers are often event by event, development by development and colored by extreme weather conditions and significant industry events, whether related to underwriting “suspensions” in certain states or to the viability of the Net-Zero Insurance Alliance. However, it’s difficult to find reports that give readers a sense of the various “forces at work” in this area. This article is an attempt to do just that while painting a picture for insurers as to what the near future might look like as they attempt to chart a course between the opposing ESG camps in the United States. Let’s start with the federal developments.

    In depth

    2024 PRESIDENTIAL ELECTION POLITICS

    Assuming US President Joe Biden is the Democratic Party’s presidential nominee next year, it seems unlikely that his stance on ESG will differ from the whole-of-government approach he announced early on in his presidency. It is expected that the US Securities and Exchange Commission will continue to press ahead with its proposed climate change risk disclosure regulation (which is reportedly slated for an October 2023 release), federal banking regulators will continue moving in the direction of requiring regulated entities to include climate change risk in lending and investment decisions, the US Department of Labor will continue to defend its position that pension trustees consider ESG factors when making investment decisions and the Federal Insurance Office (FIO) will continue to develop its approach to climate risk regulation. FIO Director Steven Seitz recently confirmed during a Federal Advisory Committee on Insurance meeting that the FIO still plans to require certain US insurers to respond to a data call on homeowners’ insurance in an effort to better understand the country’s exposure to climate risk disruptions. Despite criticism from industry and state regulators, given recent well-publicized underwriting “suspensions” in catastrophe-exposed states by leading property insurers, it seems all but certain that the FIO will press ahead with its data call. It will be quite interesting to read the FIO’s analysis of state insurance regulators’ progress with respect to climate change regulation in a report that’s due “later this summer.”

    On the Republican side, there is a growing list of candidates whose views on ESG range from skeptical to negative. If a candidate with a negative outlook on ESG is elected the next president, we can expect (at a minimum) a repeat of the country’s 2017 exit from the Paris Climate Agreement and yet another about-face by federal agencies with respect to the promulgation of ESG principles and guidelines, climate risk disclosure requirements, etc. Incidentally, the reference to “ideological joyrides” in the title of this piece is lifted from remarks Governor Ron DeSantis (R-FL) made last month when signing anti-ESG legislation into law. However, there are some Republican candidates who do believe that climate change is real and that human activity has had something to do with it. Beyond that, the candidates differ only in the vehemence of their opposition to the pro-ESG positions of Democrats and to anti-business policy solutions, such as reducing greenhouse gas emissions (e.g., recently announced presidential candidate Governor Doug Burgum (R-ND), while setting a goal to have North Dakota be carbon neutral by 2030, stated that he would prefer to have the state achieve that goal by capturing massive amounts of carbon in the state’s geology and agricultural industry.)

    12-Month Outlook: Escalating anti-ESG rhetoric is expected leading up to the 2024 presidential election. If federal agencies publish proposed pro-ESG climate change risk disclosure and/or related regulatory requirements, expect immediate court challenges by anti-ESG activists around the United States who cite to the Supreme Court of the United States’ 2022 “major question” decision in West Virginia v. Environmental Protection Agency.

    CONGRESSIONAL INVESTIGATIONS AND HEARINGS

    In recent days, there have been reports of a new US Senate “investigation” of underwriting decisions made by US insurers vis-à-vis energy companies and fossil fuel projects. This investigation, which will presumably feature hearings and testimonies from insurance industry executives, can be classified as the Democratic party’s contribution to ESG political theater in the run-up to the 2024 elections.

    Republicans in the House of Representatives are expected to continue to present their anti-ESG views, centering (presumably) on the extensive state-based anti-ESG activity—investigatory, legislative and litigation—that we have been seeing for the past year.

    12-Month Outlook: Expect more congressional hearings in both the House and Senate, with the Republican-controlled House possibly considering and passing anti-ESG legislation focused on federally regulated banks and investment managers. If such legislation is adopted by the House, it will likely not progress in the Democratic-controlled Senate.

    STATE ESG DEVELOPMENTS

    Legislative Activity during the 2023 Sessions

    This year, at least 20 “red” states considered adopting anti-ESG legislation or some sort of “resolution” opposing ESG principles. Of the states that enacted anti-ESG legislation, most were couched either in terms of “anti-boycott” measures that would prohibit states or municipalities from hiring commercial actors (banks and investment managers) that boycotted or discriminated against fossil fuel companies (e.g., Texas and North Dakota), gun manufacturers (e.g., Alabama) and/or agricultural industry participants (e.g., North Dakota) or in terms of prohibiting state actors from considering “social credit, environmental, social, governance or similar values-based or impact criteria” when making procurement or investment decisions with respect to state pension funds. In simpler terms, mandating that investment decisions consider only “pecuniary” factors.

    It’s unclear what state legislative (or other) activity the anti-ESG camp has up its sleeves for 2024, but states that did not enact anti-ESG legislation may try and make it happen still. There could also be attempts to enact laws that prohibit suing energy companies for climate change-related adaptation costs, as several states and municipalities have done (see below for more on the climate change litigation scene).

    But what about insurers specifically? The only known state to enact legislation that would impose ESG-related changes in the way insurers operate is Texas. Senate Bill (SB) 833/House Bill (HB) 1239, which is still awaiting sign-off from Governor Greg Abbott, forbids admitted insurers from using “an environmental, social or governance model, score, factor, or standard” in developing rates for similarly situated insurance buyers. The legislation contains a broad exception that protects insurers whose rating decisions “are based on an ordinary insurance business purpose, including the use of sound actuarial principles, or financial solvency considerations reasonably related to loss experience for the different types of risks and coverages made available….” Despite insurance industry opposition to the feared “balkanization” of the national marketplace, it is expected that more states will consider similar legislation next year.

    PRO-ESG STATE LEGISLATION?

    Keep in mind that some states are very much pro-ESG. For example, California legislators recently moved three pro-ESG bills forward:

    • SB 261: If the California State Assembly and Governor Gavin Newsom agree, the California Air Resources Board would be required to annually assess and report on the climate risks facing the state and summarize the various climate financial risk disclosures that certain large commercial enterprises would be required to file annually per SB 253, among other requirements.
    • SB 253: If passed, the Climate Corporate Accountability Act would require certain large businesses to disclose greenhouse gas emissions reports.
    • Assembly Bill (AB) 970: If passed by the state Senate and approved by Governor Newsom, this bill would require the California Department of Insurance to develop the Climate and Sustainability Insurance and Risk Reduction Program, which would expand insurance options, particularly for vulnerable and disadvantaged communities.

    In New York, searching legislation databases using the term “climate risk” produces more than 50 pro-ESG results for the 2023 session that just adjourned on June 10.

    In May 2023, Colorado enacted SB 16, making it the 17th state to require domestic insurers that write more than $100 million in premiums annually to submit annual climate financial risk disclosure reports using the National Association of Insurance Commissioners’ (NAIC) revised Task Force for Climate-Related Financial Disclosure (TCFD)-aligned template reporting form.

    12-Month Outlook: Expect (many) more anti- and pro-ESG legislative proposals during the 2024 state legislative sessions.

    THE NAIC

    As we have reported for the past two years, the NAIC has publicized (and continues to publicize) its efforts with respect to climate change. Tangible accomplishments apart from the updated climate change risk disclosure survey template are harder to spot. This year, Colorado and Illinois joined the 15 states that already require larger “domestic” insurers (“domestic” meaning chartered in a state that is primarily responsible for solvency regulation of those insurers) to file NAIC climate risk disclosure surveys (or use the current TCFD template) annually. While 2022 surveys are still not yet available for review, affected insurers are required to file their 2023 surveys or reports by the end of August.

    Having said this, it is unclear whether and to what extent state regulators are using their financial or solvency examination powers to require insurers to include climate risk disclosures in annual enterprise risk or Own Risk and Solvency Assessment disclosure filings. New York is the only state that has a comprehensive climate risk regulatory framework in place and the New York State Department of Financial Services, like many state regulatory agencies, is experiencing difficulties hiring and retaining experienced personnel, including personnel with the skill sets needed to analyze the adequacy of climate risk disclosures and track insurers’ adherence to their stated decarbonization targets. The NAIC’s Climate and Resiliency Task Force has made multiple climate risk and solvency analysis referrals to other NAIC committees focused on financial solvency matters but there has yet to be any responses. We may see some activity with respect to the development and use of climate risk scenario analyses and/or edits to the NAIC’s Financial Examiners Handbook later in the year.

    12-Month Outlook: Continued NAIC inaction is the most likely result due to the ongoing blue vs. red state divide with respect to climate change and ESG. However, if the FIO’s late summer report on the NAIC’s climate change regulatory progress is highly critical of state regulatory oversight, we could see some NAIC activity, possibly including “model” loss prevention and mitigation legislation and/or product development (e.g., parametric coverages) in an effort to reduce coverage gaps. Tangible progress on the development of climate-related solvency analysis and monitoring tools or protocols is less likely but still possible.

    CLIMATE CHANGE LITIGATION

    For years, suits brought against fossil fuel energy giants by states and municipalities seeking damages to cover the cost of, among other things, fortifying low-lying areas against rising sea levels and coping with increased rainfall amounts because of more frequent and more intense storms have been stalled in procedural wrangling. The key question is whether the cases should be litigated in federal courts or in state courts. Earlier this spring, the Supreme Court determined it should be state courts.

    While more preliminary litigation sparring is likely, there are roughly 25 suits currently in state courts—from Hawaii to New Jersey—that could soon proceed with discovery practice (document production requests, depositions, etc.) to determine what energy companies knew about global warming caused by their products and processes, when they knew about it and what they decided to disclose to the public. One insurer CEO characterized these cases as a “wave” of climate change-related litigation that could pose problems for the insurance industry, particularly for insurers with a history of having underwritten “old” policies for companies that are most responsible for greenhouse gas emissions going back many decades.

    Finally, keep an eye on the outcome of Held v. Montana, a suit brought by several local youths claiming that the state is failing to provide its citizens with a “clean and healthful environment” as guaranteed by the state’s constitution. The trial is ongoing in Helena, Montana.

    12-Month Outlook: Expect more suits by states and municipalities seeking damages for costs to adapt to warmer, wetter and stormier climate conditions. And perhaps an upsurge of suits alleging corporate greenwashing should federal and state regulators become significantly more active in policing sustainability or decarbonization claims.

    Authors

    Thomas M. Dawson

    Partner

    New York – One Vanderbilt Avenue

    More insights

  • Key Takeaways | Putting Employee Wellness Programs to Work

    Key Takeaways | Putting Employee Wellness Programs to Work

    ARTICLE

    Key Takeaways | Putting Employee Wellness Programs to Work

    June 16, 2023

    Read time: 3 min

    Key takeaways
    Overview

    During this session, panelists discussed the unique opportunities and challenges of digital-health wellness programs that partner with employers and health plans in considering, adopting and operationalizing wellness programs across their employee populations. The panelists discussed a wide range of challenges and opportunities, including accessibility to employees, navigating the health plan regulatory landscape, and being mindful of budgetary constraints and the reality of rising healthcare costs.

    Session panelists:

    • Denise Bloch, Vice President and Associate General Counsel, Regulatory and Compliance, SWORD Health
    • Tsion Lencho, Co-Chief Executive Officer, Cleo
    • Emily Taylor, Chief Financial Officer, Wondr Health
    • Sarah Raaii, Partner, McDermott Will & Emery
    • Moderator: Scott Weinstein, Partner, McDermott Will & Emery
    In depth

    Top takeaways included:

    1. Trends in employee health include looking for ways to drive healthcare costs down, which often involves adoption of employee wellness solutions, particularly digital-health wellness solutions.
    2. Employers are balancing the desire to find and adopt a “full-scale” solution that meets the unique needs of their workforce, while also considering budgetary constraints, the likelihood of employee utilization and the costs of implementing new benefits solutions.
    3. When implementing wellness programs, employers should be aware that they may be subject to the Employment Retirement Income Security Act (ERISA), the Health Insurance Portability and Accountability Act (HIPAA), or other laws and regulations governing health plans (e.g., the Consolidated Omnibus Budget Reconciliation Act (COBRA)) if the program involves the provision of medical care to employees. Employers and/or health plans may request compliance assistance from their digital-health wellness programs, and digital-health companies should tread carefully to avoid liability for such compliance.
    Authors
    More insights

  • Top Takeaways | 2023 Digital Health Forum | Behavioral Health 2.0: Post-Pandemic Priorities

    Top Takeaways | 2023 Digital Health Forum | Behavioral Health 2.0: Post-Pandemic Priorities

    ARTICLE

    Top Takeaways | 2023 Digital Health Forum | Behavioral Health 2.0: Post-Pandemic Priorities

    June 16, 2023

    Read time: 3 min

    Key takeaways
    Overview

    In this session, the panel discussed the opportunities digital health offers currently for behavioral-health care, and what might be around the corner.

    Session panelists included:

    • Robert Hasty, General Counsel, Pelago (formerly Quit Genius)
    • Tiffany Lin, Co-Founder and Chief Executive Officer, Daylight Health
    • William Robinson, Head of Policy and Strategy, Big Health
    • Moderator: James A. Cannatti III, Partner, McDermott Will & Emery
    In depth

    Top takeaways included:

    • Accessing quality care. Digital health—including the technology itself and the care models based on it—has become a valuable addition to the healthcare ecosystem, offering increased access to critical behavioral-health care through, for example, 24/7 chat services, that otherwise may be out of reach for patients, especially for those in rural and marginalized communities. It also has played a significant role in destigmatizing behavioral health by breaking down barriers to treatment and providing platforms for individuals to seek support in convenient settings.
    • Filling the gap. The shortage of clinicians has contributed to a tangible absence of specialty behavioral health providers. One example, pediatric psychiatry, continues to have a high demand but, unfortunately, many patients are met with a low supply of clinicians. Digital health helps fill an important gap in providing access to behavioral-health care.
    • Hybrid treatment options. Implementing a hybrid treatment model that incorporates digital and in-person touchpoints can optimize scalability in digital healthcare. A hub-and-spoke model, in which digital tools are embedded within existing systems, offers a balance between prioritizing patients’ needs to receive care in a comfortable setting and the importance of assessing and referring individuals with more serious conditions to appropriate outpatient or inpatient programs.
    • Across the pond. In markets such as the United Kingdom, the National Health Service (NHS) has actively explored and adopted digital-health solutions to enhance patient care and streamline healthcare delivery. In many cases, patients have access to digital-first mental health services at no cost to them. Lessons learned from the UK and other markets may help shape future approaches to digital behavioral health in the United States.
    • Reimbursement landscape. Coverage and reimbursement often lags behind the science. This is particularly true regarding digital behavioral health. Finding market strategies that allow for patients to access care is critical. Expect to see continued leveraging of business-to-business (B2B) models and value-based care arrangements as new opportunities and approaches are also explored.
    Authors

    James A. Cannatti III

    Partner

    Washington, DC

    More insights

  • In Case You Missed It: Highlights | When Digital and Life Sciences Intersect

    In Case You Missed It: Highlights | When Digital and Life Sciences Intersect

    ARTICLE

    In Case You Missed It: Highlights | When Digital and Life Sciences Intersect

    June 16, 2023

    Read time: 5 min

    Key takeaways
    Overview

    In this session, panelists discussed common pitfalls that life sciences companies face as they explore ways to incorporate digital-health strategies into product and service offerings, as well as approaches for successful integration and launch. Seasoned veterans in developing and deploying digital-health solutions from within the life sciences ecosystem, the panelists shared lessons learned and offered practical suggestions for listeners addressing similar projects.

    Session panelists:

    • David S. Klimstra, MD, Founder and Chief Medical Officer, Paige.AI, Inc.
    • Suhas Krishna, Vice President, Head of Product Management, Digital Health, Bristol Myers Squibb
    • Betsy McSheffrey, Head Counsel, Data, Technology and Innovation, Takeda
    • John Rootenberg, MD, Principal Director, Digital Safety and Decision Support, Genentech (Roche)
    • Ryan Sysko, Chief Executive Officer, Amalgam RX
    • Moderator: Jennifer Geetter, Partner, McDermott Will & Emery
    In depth

    Top takeaways included:

    Challenges

    1. Last-mile conundrum. Panelists observed that for typical products manufactured by life sciences companies, a disproportionate amount of the hard work occurs prior to regulatory approval. Once the product is approved (by, for example, the Clinical Laboratory Improvement Amendments (CLIA) or the US Food & Drug Administration (FDA), the company’s most difficult work is done. For digital-health solutions, the inverse is often true. Even sophisticated digital-health products and services typically have a shorter development timeline, but once released in the market, challenges around adoption, adherence, persistence and integration must be addressed. In addition, customers will expect regular software updates. Life sciences companies are not always adequately prepared for this reverse last mile—i.e., the longest mile—of the development and marketing lifecycle.
    2. Risk appetite. Panelists noted that the life sciences industry is typically risk averse. This is in sharp contrast, for example, to the software industry, which is attuned to software innovations and is designed to anticipate missteps and optimize, when necessary, the “fast fail.”
    3. Blurry strategic vision. The panelists discussed “digital-health FOMO” (fear of missing out). Life sciences companies want to offer digital-health products and services because they recognize the strategic value of participating in the market explosion at the intersection of healthcare and data/computing. Sometimes this enthusiasm outpaces the speed with which life sciences companies can develop dedicated digital-health strategies, either as companions to existing products or as complimentary clinical services. Having a clear strategic objective governing the development of a product and realistic investment goals are critical.
    4. Deployment. The panelists emphasized that once a digital health tool is developed, companies should ensure physicians and patients actually adopt and continue to use the tool. Specifically, one panelist stated, “The one who wins is the one who has the right deployment [of the tool].”

    Opportunities

    1. Hidden value. Digital-health strategies, such as using the data obtained from digital-health tools to promote research, offer hidden value for life science companies. As a component of development and marketing strategy, life sciences companies need to be prepared to articulate these benefits, especially those that may not be readily apparent or may be ancillary benefits. The successful deployment of a digital-health tool—for example, a patient- or consumer-facing app—is predicated on the persistent adoption of that tool. It must create discernible value for users; otherwise, they would likely not continue to use the app.
    2. Strategy of quick wins. In considering steps companies can take when adopting digital-health strategies, panelists recommended having “quick wins” that demonstrate outcomes that can be reproduced. This creates momentum and builds confidence.
    3. Executive sponsorship. Digital-health products and services typically straddle multiple departments. They require significant cross-functional cooperation and can languish without dedicated executive sponsorship. But the presence of strong leaders who champion these products and services—in particular, individuals with decision-making authority, deep understanding of the regulatory lifecycle for these products, and knowledge of the normative and operational constraints that physicians and patients experience when using them—can pay dividends.
    4. Don’t fear HIPAA. Panelists agreed that life sciences companies distort the risk of Health Insurance Portability and Accountability Act regulation, to the detriment of product design and deployment. HIPAA presents a manageable set of privacy and security standards. If deploying the tool in a HIPAA-regulated capacity has advantages—and, from a data-rights perspective, it often does—life sciences companies should not overestimate the risk of this decision.
    5. Strategize your data plan. Panelists recommended that companies ask questions, up front, surrounding the desired data strategy. Such questions should include the types of information and data rights they wish to collect and use. It is much more difficult to reverse-engineer the collection of information or data rights if they were not captured initially. Companies should build their data strategy into their protocols early in the development process.
    Authors

    Jennifer S. Geetter

    Partner

    Washington, DC

    More insights

  • Key Takeaways | CEO and Founder Perspective: Provider Spotlight

    Key Takeaways | CEO and Founder Perspective: Provider Spotlight

    ARTICLE

    Key Takeaways | CEO and Founder Perspective: Provider Spotlight

    June 16, 2023

    Read time: 3 min

    Key takeaways
    Overview

    During this session, CEOs and founders of transformative digital-health companies shared their experiences and offered thoughts on today’s market and where care delivery is heading next.

    Session panelists:

    • Priyanka Jain, Chief Executive Officer and Co-Founder, Evvy
    • Naveen Kathuria, Chief Executive Officer, GoCheck Kids
    • Kristina Saffran, Chief Executive Officer and Co-Founder, Equip
    • Moderator: Marshall E. Jackson, Jr., Partner, McDermott Will & Emery
    In depth

    Top takeaways included:

    1. Virtual-care platforms and digital-health technologies continue to reduce barriers by bringing care directly into the home and expanding access to culturally competent care.
    2. Digital-health tools help increase provider access to data and inform patients about new research findings and other relevant developments they may wish to raise with providers during care visits.
    3. Advances in women’s health continue to lag, but digital-health providers are closing the gap by using enhanced data collection and analysis to develop new care pathways designed specifically for women.
    4. Patient and provider education is critical to the successful adoption and use of digital-health tools. However, choice of technology impacts adoption and continued use of digital-health platforms. For example, the leveraging of smartphones that providers and patients are already accustomed to using may yield greater results, as compared to the use of unique or custom devices that require training to use correctly.
    5. Market focus is shifting from access to quality. As economic conditions change, digital-health platforms that seek new funding will face pressure to prove that their offerings not only increase access, but actually improve outcomes.
    Authors

    Marshall E. Jackson , Jr.

    Partner

    Washington, DC

    More insights

  • Key Takeaways | Regulatory Roadblocks and Opportunities: How to Thrive in a Shifting Healthcare Landscape

    Key Takeaways | Regulatory Roadblocks and Opportunities: How to Thrive in a Shifting Healthcare Landscape

    ARTICLE

    Key Takeaways | Regulatory Roadblocks and Opportunities: How to Thrive in a Shifting Healthcare Landscape

    June 16, 2023

    Read time: 3 min

    Key takeaways
    Overview

    During this session, panelists offered insights into the regulatory action, rulemaking and legislation shaping the future of digital health, with a particular focus on artificial intelligence (AI), data privacy and the end of the COVID-19 public health emergency (PHE).

    Session panelists:

    • Lucia Savage, Chief Privacy and Regulatory Officer, Omada Health, Inc.
    • Latoya S. Thomas, Head of Policy and Government Affairs, Included Health
    • Kate Tipping, Deputy Director, Regulatory and Policy Affairs Division Office of the National Coordinator for Health Information Technology (ONC)
    In depth

    Top takeaways included:

    1. As the landscape changes, multiple regulatory entities continue to look closely at digital health, especially telemedicine and AI. Agencies are contemplating how to regulate effectively while focusing on the advancement of health equity and social determinants of health.
    2. ONC is proposing additional transparency requirements for AI in Certified Health IT through its recently proposed rule Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing (HTI-1). Through these new proposed transparency requirements, ONC is focused on promoting trust and increasing adoption by providers of AI tools embedded within Certified Health IT products. However, given that certain uses of AI in healthcare are already regulated by the US Food & Drug Administration, these new proposals may add additional regulatory layers to AI outside of current authorities.
    3. The end of PHE flexibilities is causing frustration and increased costs of compliance among digital-health providers. For example, the expiration of eased restrictions regarding the cross-border practice of medicine and other scope-of-practice limitations is requiring digital-health platforms to confirm that providers are appropriately licensed in applicable states and that care teams comprise providers practicing within the scope of their license.
    4. Industry stakeholders would like to see the US Centers for Medicare and Medicaid Services (CMS) take action on reimbursement for asynchronous telehealth services, primarily because the historical paradigm of reimbursing for synchronous telehealth services provided by a distant site to an originating site no longer reflects effective telehealth modalities in use today.
    Authors
    More insights

  • Just Catching Up? SECURE 2.0 Roth Catch-Up Contribution Requirement Leaves More Questions than Answers

    Just Catching Up? SECURE 2.0 Roth Catch-Up Contribution Requirement Leaves More Questions than Answers

    ARTICLE / CLIENT ALERT

    Just Catching Up? SECURE 2.0 Roth Catch-Up Contribution Requirement Leaves More Questions than Answers

    June 20, 2023

    Read time: 4 min

    Key takeaways
    Overview

    In this series of articles, we explore the implications of SECURE 2.0’s changes to catch-up contributions and how employers should respond.


    Employers can offer participants who are age 50 or older the opportunity to make additional catch-up contributions to their retirement plans. Doing so provides a great way for older workers to save more money—up to an extra $7,500 for 2023—as they get closer to retirement age. As a result, studies suggest that as many as 98% of plans offer catch-up contributions.

    Historically, those plans could offer all participants the choice to make catch-up contributions on a pre-tax and/or Roth basis. However, the SECURE 2.0 Act changes all that. Beginning after December 31, 2023, SECURE 2.0 indicates that any plan that permits catch-up contributions must require certain employees—i.e., those whose wages from their employer exceed $145,000 in the prior calendar year—to make their catch-up contributions on a Roth basis. This change raises a host of questions about how the rule is intended to apply in practice and even more concerns about the operational obstacles employers will face in attempting to implement the change by year-end. As a result, industry groups have already begun to push for priority guidance, transition relief and delayed effective dates to provide employers sufficient time to work with their recordkeepers and payroll providers to implement this change.

    Until that guidance is issued, however, employers continue to raise questions about a myriad of issues, including the following:

    • Implementation challenges for plans using spillover and separate contribution elections;
    • Use of a special definition of wages for purposes of applying the $145,000 limit;
    • Impact of the $145,000 limit on mid-year hires and employees with variable pay;
    • Ability to require all employees, not just those making more than $145,000, to make catch-up contributions on a Roth basis; and
    • Inability to prevent employees who exceed the $145,000 limit from making catch-up contributions without eliminating catch-up contributions from the plan entirely.

    Despite the many questions that remain, it is important for employers to coordinate with their recordkeepers and payroll providers as soon as possible to ensure that they understand the potential impact of the change, which systems will need to be updated to address it and who will bear that responsibility. Importantly, changes that require payroll and recordkeeping coordination often take many weeks, and even months, to implement and test. Therefore, employers will need to continue planning for these changes while they look forward to future guidance. This will be even more pressing for plans that do not currently offer Roth contributions and will need to add it to their plans to facilitate this change.

    For any questions regarding SECURE 2.0 changes, please contact your regular McDermott lawyer or one of the authors.

    ***

    Read Second Article: Just Catching Up? All for One, or None for All, Catch-Up Contributions Under SECURE 2.0

    Read Third Article: Just Catching Up? Wages, by Any Other Name, Not So Sweet for Employers Under SECURE 2.0

    Read Fourth Article: Just Catching Up? Payroll Challenges Plague Roth Catch-Up Contribution Implementation

    Read Fifth Article: Just Catching Up? Oops! Congress Clarifies Catch-Up Contributions Are Here to Stay

    Read Sixth Article: Just Catching Up? For SECURE 2.0’s Catch-Up Contributions, Age Is More Than Just a Number

    In depth
    Authors

    Brian J. Tiemann

    Partner

    Chicago

    More insights

  • Inside the ONC’s Plans to Regulate Health AI: Proposal on Predictive Decision Support Interventions

    Inside the ONC’s Plans to Regulate Health AI: Proposal on Predictive Decision Support Interventions

    ARTICLE / REPORT

    Inside the ONC’s Plans to Regulate Health AI: Proposal on Predictive Decision Support Interventions

    June 14, 2023

    Read time: 2 min

    Key takeaways
    Overview

    The Department of Health and Human Services Office of the National Coordinator for Health Information Technology (ONC) published a notice of proposed rulemaking on April 18, 2023, titled “Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing,” or HTI-1.

    HTI-1 includes proposals that would create new transparency and risk management expectations for artificial intelligence (AI) and machine learning (ML) technology that aid decision-making in healthcare. Importantly, ONC’s proposal includes requirements for a broad set of technologies based on algorithms or models that could be used by many types of users, for any purpose, irrespective of the technology’s risk profile and regardless of who developed the algorithm or model. If finalized, ONC’s HTI-1 proposal for AI/ML technologies they define as “Predictive Decision Support Interventions” will significantly impact the development, deployment and use of AI/ML tools in healthcare. As of June 14, 2023, comments on the HTI-1 proposed rule are due on June 20, 2023.

    In depth
    Authors
    More insights

  • Euro Vision on Corruption: All Singing from the Same Song-Sheet? Proposals for a New Anti-Corruption Legal Framework in the EU: Five Key Takeaways

    Euro Vision on Corruption: All Singing from the Same Song-Sheet? Proposals for a New Anti-Corruption Legal Framework in the EU: Five Key Takeaways

    ARTICLE / CLIENT ALERT

    Euro Vision on Corruption: All Singing from the Same Song-Sheet? Proposals for a New Anti-Corruption Legal Framework in the EU: Five Key Takeaways

    June 14, 2023

    Read time: 13 min

    Key takeaways
    Overview

    On 14 September 2022, the President of the European Commission, Ursula Von Der Leyen, announced the Commission’s commitment to “update the EU’s legislative framework on anti-corruption to better prevent and fight corruption across the European Union in the future”.1

    Following this, on 3 May 2023, the European Commission proposed a draft set of measures to strengthen the legal anti-corruption framework across all EU Member States. These measures consist of the following:

    (i) a proposed directive on combatting corruption2 (the “Proposed Directive”); and

    (ii) a dedicated sanctions regime “to fight serious acts of corruption worldwide,”3 to complement the EU’s Common Foreign and Security Policy (“CFSP”).

    This article summarises the new measures, examines key aspects of anti-corruption law in France and Italy in light of the Proposed Directive, and considers its potential impact on the anti-corruption landscape in the United Kingdom.

    In depth

    The Proposed Directive

    The Proposed Directive aims to update and harmonise EU anti-corruption frameworks, definitions and penalties for breaches, which currently vary across Member States. It covers several aspects, including:

    (i) comprehensive and up-to-date preventive anti-corruption measures for the public and private sectors, “adapted to the specific risks of an area of activity” (Art. 3)4;

    (ii) specialised bodies dedicated to the prevention5 and repression of corruption, which are functionally independent from the government and adequately resourced (Art. 4);

    (iii) definitions of public, private, passive and active bribery. These offences must be “punishable as a criminal offence when committed intentionally” (Arts. 7 and 8);

    (iv) definitions of related offences, such as misappropriation, trading in influence, abuse of functions, obstruction of justice and illicit enrichment from corruption (Art. 9 to 13);

    (v) harmonised minimum penalties and specific measures for natural persons, with terms to range from at least four to a maximum of six years imprisonment depending on the offence (Art. 15);6

    (vi) liability and penalties for legal entities under specific conditions, with maximum fines imposed being not less than 5% of the total worldwide turnover of the entity and related entities in the previous financial year (Arts. 16 and 17); and

    (vii) harmonised minimum limitation periods for corruption offences (Art. 21).

    The Proposed Directive contains a dual focus on preventing corruption before it occurs (for example, through education and research programmes) and repressing corrupt acts (for example, through criminal investigation and enforcement).

    In the context of recent EU legislative development regarding the protection of whistleblowers, the Proposed Directive reiterates the importance of protecting those who report corruption offences and assist relevant investigations. It is also in line with broader efforts by the EU to harmonise the enforcement of serious crime across Member States. For example, in November 2022, the Council of the EU adopted7 a decision to add the violation of EU sanctions to the list of “EU crimes”, which include corruption, amongst others. This decision was soon followed by the proposal of a directive8 setting out the criminal offences and penalties applicable to breaches of EU sanctions laws.

    While the Proposed Directive may be subject to change as it goes through the EU’s legislative process, the latest draft (as at the time of writing) states that Member States will have 18 months to transpose the final Directive into their domestic law.

    A potential dedicated EU sanctions regime focusing on corruption

    On 3 May 2023, the Commission and the High Representative stated9 that a coherent approach “between internal and external [EU] anti-corruption policies” is essential for the credibility of the EU’s anti-corruption framework.

    To add “more flexibility to the Union’s sanctions toolbox,” a Council decision and a Council regulation are being considered to establish a thematic framework (i.e., not limited to a specific geographic context) targeting corruption under the EU’s sanctions regime. This proposal, which is still in its infancy, would enable the EU to impose sanctions on persons or entities involved in “serious acts of corruption” which “seriously affect or risk affecting the fundamental interests of the Union and the objectives of the CFSP”.10 This would not be the first thematic framework available to the EU when imposing sanctions; the EU currently has powers to impose restrictive measures in response to matters such as serious human rights violations, terrorism, the proliferation and use of chemical weapons, and cyberattacks.

    Commentary

    France

    France has made significant progress in the fight against corruption by introducing ground-breaking preventive legislation. The law of 9 December 2016, known as the “Sapin II Law”, imposes an obligation to establish and maintain a global anti-corruption compliance programme on (i) companies incorporated in France and (ii) foreign companies not headquartered in France, falling within specific criteria.11 A failure to enact such a programme may lead to companies facing administrative sanctions and criminal penalties even where no corrupt activity is identified on the part of that company.

    The Sapin II Law also created the French Anti-Corruption Agency (“AFA”). The AFA oversees public and private entities and, with its sanctions commission, engages in enforcement action in France and abroad against entities that do not meet their preventive obligations.12 The AFA has already investigated more than 150 entities, with an average duration of 18 months for each investigation.13

    In addition to the creation of the AFA, which focuses on preventive requirements, the National Financial Prosecutor’s Office (“PNF”) prosecutes offences such as corruption, trading in influence, favoritism and misappropriation of public funds (thus focusing on “repressing” corruption). Since 2016 and the implementation of the French Judicial Public Interest Agreement (Convention judiciaire d’intérêt public, or CJIP) – a form of deferred prosecution agreement – enforcement relating to these offences has increased significantly.

    In accordance with the Proposed Directive, the French criminal code already distinguishes between bribery in the public sector and the private sector, as well as active and passive bribery. The French criminal code also contains several related offences, as listed in the Proposed Directive, such as trading in influence.

    Overall, the French anti-corruption legal framework, both in its preventive and repressive components, aligns with the objectives of the European Commission. The Proposed Directive’s requirement on Member States to enact “up-to-date measures to prevent corruption”14 may even cause other Member States to follow France’s lead by penalising corporates for not having an adequate compliance programme.

    Italy

    In recent years, Italy has expanded the set of rules targeting corruption, with significant results. Among the most impactful reforms, Law No. 190/2012 established the Italian Anti-Corruption Authority (“ANAC”), a financially and politically independent authority for the prevention of corruption, with regulatory and supervisory powers over public procurement and administration, monitoring powers in relation to the anti-corruption system generally, and sanctioning powers. More recently, Law No. 3/2019 (the so-called “Sweep-the-Corrupt” law) further amended the Criminal Code, with the aim of strengthening the prevention, detection and repression of corruption.  On 30 March 2023, the Legislative Decree No. 24/2023 implementing the Directive (EU) 2019/1937 on whistleblowing, finally entered into force with effect from 15 July 2023 and strengthened the existing legislation relating to the protection of whistleblowers.

    In the last 12 years, Italy has consistently improved its scoring in Transparency International’s Corruption Perception Index and, in 2022, scored 56 out of 100 (where 0 is “highly corrupt” and 100 is “very clean”). This is an important improvement considering that Italy scored 42 out of 100 in 2012; however, the latest rank is still below the EU-Western European average score of 66 out of 100).

    Thus, the fight against corruption is still essential, especially in connection with the major investments and projects expected to be realised with the funds made available by the EU to Member States, in the context of the Next Generation EU Plan. Italy is planning to use such funds (approximately €191 billion) and a further €30.6 billion of national funds to realise the National Recovery and Resilience Plan, including, amongst other initiatives, (i) investments to complete the digital transformation, (ii) the transition to sustainable energy sources and (iii) the creation of new infrastructures to support the economic growth. Corruption risk may occur in the selection of suppliers and contractors, and criminal organizations may be tempted to influence the selection process in favour of companies linked to them. Therefore, the President of the ANAC welcomed the Proposed Directive emphasising the importance of the measures aimed at preventing corruption and the role given to independent authorities.

    The set of rules targeting corruption currently in place are already along the lines of the Proposed Directive, even if some differences in the definition of offences may exist and further adjustments may be made to the Proposed Directive before it is enacted. The outcome of the mapping of the high-risk areas by the Commission (expected for 2024) remains to be seen, as well as the possible subsequent implementation of the preventive measures set by Article 3 of the Proposed Directive (e.g., awareness-raising actions, plans to address the risk in the identified sectors).

    United Kingdom

    The Proposed Directive does not go so far as to mandate that Member States enact a “strict liability” corporate offence of failure to prevent bribery by persons associated with the company, which exists under Section 7 of the UK Bribery Act 2010 (although it is open to Member States to take such a step). However, it does require Member States to impose corporate liability where there has been a lack of supervision or control by senior management (as defined under Article 16(1) of the Proposed Directive), which “has made possible the commission of any of the criminal offences” listed in the Proposed Directive.15

    It is noteworthy that the Proposed Directive refers to corruption in both the public and private sectors and includes provisions for corporate criminal liability where there have been compliance failings, which tracks the approach taken in the UK. Additionally, certain steps that Member States may be required to take under Article 3 of the Proposed Directive (such as rules “for the disclosure and verification of assets of public officials”) may go further than those currently provided for in the UK’s anti-corruption laws, depending on how they are implemented.

    It is also of interest that, at Article 16, the Proposed Directive provides that a corporate entity can be liable for any of the offences listed, when committed for its benefit by natural persons having a “leading position” within the entity. A leading position within the entity is based on “(a) the power of representation of the legal person; (b) the authority to take decisions on behalf of the legal person; or (c) the authority to exercise control within the legal person.” This differs in some respects from the position in English law, where a person’s seniority in the company does not necessarily mean they are acting as the “directing mind and will” of the company (thus making the entity liable for their misconduct).

    Naturally, while the Proposed Directive would not have any direct application to the UK, as it is no longer part of the EU, it does suggest the potential for greater cooperation between the UK, its European counterparts and other third-country jurisdictions. In particular, the authorities in the UK will no doubt be carefully monitoring how any new “specialised bodies” put in place by Member States will be resourced and how they approach requests for mutual legal assistance made by their international counterparts.

    Separate from the Proposed Directive, the potential new EU anti-corruption sanctions regime is yet another indicator of increasingly harmonised standards internationally. The UK enacted a dedicated global anti-corruption sanctions regime in 2021.16 Under this regime, the UK government can sanction those who are involved in “serious corruption”. At the time of writing, 35 individuals have been designated under this regime.

    Five key takeaways

    The following are key takeaways from the publication of the Proposed Directive:

    (i) the Proposed Directive has been published at a time when there have been a number of significant developments in the white-collar space globally, including in particular (i) the  recent development of new corporate “failure to prevent” offences in the UK (covering inter alia fraud, false accounting and money laundering), (ii) the memorandum released in September 2022 by US Deputy Attorney General Lisa Monaco on Corporate Crime and Enforcement17 and (iii) the March 2023 updates to the US Department of Justice guidance on the Evaluation of Corporate Compliance Programs.18  The Proposed Directive is part of the efforts of the European Commission to maintain focus on the fight against corruption and participate further in the increasing international alignment on these issues;

    (ii) while the Proposed Directive indicates increasing harmonisation of anti-corruption requirements across the EU, it only prescribes minimum standards. Member States will, therefore, be able to implement or maintain stricter obligations. Additionally, as the proposal takes the form of a directive, Member States will be afforded a degree of freedom as to how they choose to implement its provisions. It will therefore be important for companies with operations across several Member States to consider any differences or nuances that apply under local law. To the extent that such differences exist, companies may need to adopt a “highest common denominator” approach of designing policies and procedures that meet the requirements of those jurisdictions with the strictest obligations;

    (iii) in terms of enforcement, harmonisation across the EU, which seems broadly to align with the UK and the United States, will make it easier for law enforcement agencies around the world to cooperate in the investigation and prosecution of multinational companies that engage in corrupt activities in or from the EU; it also sends a clear message to jurisdictions with high levels of corruption that the EU will not tolerate misconduct that is damaging to EU interests;

    (iv) the Proposed Directive also reflects the recent initiatives of Member States that focus on the prevention of corruption as opposed to focusing solely on prosecuting corrupt acts (i.e., “repressing” them). The harmonised concept of prevention is stated to be “the detection and elimination of the causes of and conditions for corruption, through development and implementation of a system of appropriate measures, as well as deterrence against corruption-related acts”. In that regard, special reference is made to the creation of bodies “specialised in the prevention of corruption,” in addition to those “specialised in the repression of corruption”; and

    (v) companies within the scope of the Proposed Directive and relevant national laws may benefit from adopting the harmonised definitions of public, private, active and passive bribery, and related offences within the Proposed Directive.19 This may become even more important if the Proposed Directive is enacted and companies find themselves subject to the supervision of newly established bodies (or under increased scrutiny from existing agencies with a renewed focus on anti-corruption).20

    In short, it appears that similar approaches to anti-corruption prevention and enforcement are being adopted in a number of advanced jurisdictions around the world. This is not considered to be mere coincidence. There is also evidence of increased co-operation between law enforcement agencies around the world, plus increased sharing of data, intelligence and investigation techniques. Multinational companies should therefore seek to harmonise their own approach to compliance and prevention in the various countries in which they operate, whilst at the same time taking account of key differences where they exist. This requires a fairly constant cycle of risk assessment, monitoring and review, but is one that need not be overly burdensome once the basic processes are in place.

     

    Authors

    Simon Airey

    Partner

    London – 22 Bishopsgate

    Nicolette Kost De Sèvres

    Partner

    Washington, DC, Paris

    Fabio Cozzi

    Partner

    Milan

    William Merry

    Senior Associate

    London – 22 Bishopsgate

    More insights